- Home
- SAGE vs INNV Comparison
SAGE vs INNV Comparison
Compare SAGE & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- INNV
- Stock Information
- Founded
- SAGE 2010
- INNV 2007
- Country
- SAGE United States
- INNV United States
- Employees
- SAGE N/A
- INNV N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- INNV Medical/Nursing Services
- Sector
- SAGE Health Care
- INNV Health Care
- Exchange
- SAGE Nasdaq
- INNV Nasdaq
- Market Cap
- SAGE 413.9M
- INNV 482.0M
- IPO Year
- SAGE 2014
- INNV 2021
- Fundamental
- Price
- SAGE $6.46
- INNV $4.09
- Analyst Decision
- SAGE Hold
- INNV Sell
- Analyst Count
- SAGE 19
- INNV 2
- Target Price
- SAGE $9.88
- INNV $5.00
- AVG Volume (30 Days)
- SAGE 815.0K
- INNV 35.1K
- Earning Date
- SAGE 04-29-2025
- INNV 05-06-2025
- Dividend Yield
- SAGE N/A
- INNV N/A
- EPS Growth
- SAGE N/A
- INNV N/A
- EPS
- SAGE N/A
- INNV N/A
- Revenue
- SAGE $47,404,000.00
- INNV $831,683,000.00
- Revenue This Year
- SAGE $103.73
- INNV $13.86
- Revenue Next Year
- SAGE $41.15
- INNV $10.75
- P/E Ratio
- SAGE N/A
- INNV N/A
- Revenue Growth
- SAGE N/A
- INNV 12.19
- 52 Week Low
- SAGE $4.62
- INNV $2.60
- 52 Week High
- SAGE $13.47
- INNV $6.69
- Technical
- Relative Strength Index (RSI)
- SAGE 38.73
- INNV 65.33
- Support Level
- SAGE $6.36
- INNV $3.96
- Resistance Level
- SAGE $6.78
- INNV $4.29
- Average True Range (ATR)
- SAGE 0.24
- INNV 0.23
- MACD
- SAGE -0.01
- INNV -0.01
- Stochastic Oscillator
- SAGE 12.22
- INNV 57.58
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.